Pharmaceuticals & Biotechnology (4570)

21,228.55
   
  • 52 Week High: 24,649.93
  • 52 Week Low: 18,687.04

Latest ShareCast News

Indivior to cancel secondary listing in London

By Benjamin Chiou

Date: Monday 02 Jun 2025

(Sharecast News) - Drugmaker Indivior has announced plans to cancel its secondary listing in London, just a year after moving its primary listing to the Nasdaq.

GSK's linerixibat to be reviewed by US FDA

By Iain Gilbert

Date: Monday 02 Jun 2025

(Sharecast News) - Drugmaker GSK revealed on Monday that a new drug application for its linerixibat asset had been accepted for review by the US Food and Drug Administration for use in cholestatic pruritus patients with primary biliary cholangitis.

Aptamer signs second Optimer programme contract with Unilever

By Iain Gilbert

Date: Friday 30 May 2025

(Sharecast News) - Biotechnology firm Aptamer announced on Friday that it has secured a second Optimer discovery and development programme with global consumer goods leader, Unilever.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 21,228.55
Closing Price Change 545.13
% Change 2.64 %
30-May-25 Close 21,228.55

Top Risers

Price Change
SCLP 10.30p +3.0%
VRCI 1.29p +2.9%
ANIC 6.34p +2.3%
AREC 44.33p +1.9%
POLB 3.25p +1.6%
ANCR 282.29p +0.8%
GSK 1,517.00p +0.7%
FARN 263.82p +0.5%
HCM 208.00p +0.5%
HIK 2,142.00p +0.1%

Top Fallers

Price Change
CIZ 1.77p -24.8%
APTA 0.35p -8.0%
OPTI 13.38p -7.8%
IXI 10.75p -4.4%
AVCT 36.75p -3.3%
BXP 35.80p -3.2%
N4P 0.46p -3.2%
ONT 120.30p -2.5%
STX 2.35p -2.1%
GUN 0.12p -2.0%

Top of Page